Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Cyproheptadine

129-03-3C21H21N287.406 g/mol

The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number129-03-3ChEBI ↗
Molecular formulaC21H21NChEBI ↗
Molar mass287.406 g/molChEBI ↗
Monoisotopic mass287.1674 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:4046ChEBI ↗

Cross-source molecular data

PubChem
Molar mass287.4 g/molPubChem ↗
Exact mass287.167399674 DaPubChem ↗
Computed XLogP4.7PubChem ↗
Topological polar surface area (Ų)3.2PubChem ↗
H-bond donors0PubChem ↗
H-bond acceptors1PubChem ↗
Rotatable bonds0PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
cyproheptadine
4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine
JJCFRYNCJDLXIK-UHFFFAOYSA-N
CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3

Names & synonyms

4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidineciproheptadinacyproheptadinum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antiviral agentanalgesicH1-receptor antagonistserotonergic antagonistanti-allergic agentgastrointestinal drugantipruritic drug

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.0034794 mol

Uses 287.406 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 21 atoms
87.76%
H
Hydrogen · 21 atoms
7.37%
N
Nitrogen · 1 atom
4.87%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
First pharmacophoric hypothesis for 5-HT7 antagonism. ↗Bioorganic & medicinal chemistry letters · 2000 May 15 · PMID 10843226
US3014911 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:4046

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 2913 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.